🔎 Trials Near Me

Home › NCT07284472

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

RecruitingPhase 2/3

Phase 2/3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Participants With Alzheimer's Disease Dementia

Who can join

Ages 55 to 90 · All sexes

Full eligibility criteria
Inclusion criteria:

1. The participant is an adult male or female between the ages of 55 to 90 years inclusively, who can move around by themselves, with a walker or a wheelchair.
2. A previously established diagnosis of AD dementia.
3. The participant has clinically significant, moderate/severe agitation at the time of screening and for at least 2 weeks prior to randomization
4. The diagnosis of agitation must meet the International Psychogeriatric Association (IPA) provisional definition of agitation.
5. Caregiver who is able and willing to comply with all required study procedures and who is in contact with the participant at least on four individual days for at least two hours per day.

Exclusion criteria:

1. The participant has a confirmed primary diagnosis of a dementia-related disease other than AD dementia.
2. The participant has symptoms of agitation that are not secondary to AD dementia
3. The participant has a history of uncontrolled seizures or a history of epilepsy.
4. The participant has a major medical illness or unstable medical condition

About the study

The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.

What is being tested

Sponsor: Exciva GmbH · Participants: 300 · Started: Feb 2, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07284472

Locations in the U.S.

CaliforniaEsperanza Clinical, Murrieta
IndianaJosephson Wallack Munshower Neurology PC, Indianapolis
MississippiPrecise Research Centers, Flowood
MissouriGalen Research LLC, Chesterfield (Not yet recruiting)
New YorkIntegrative Clinical Trials, Brooklyn
Manhattan Behavioral Medicine, New York
OhioInsight Clinical Trials, Independence
OregonOregon Health & Science University, Portland (Not yet recruiting)
VermontThe Memory Clinic, Bennington

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.